HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy.

AbstractCONTEXT.—:
In women, radical cystectomy includes removal of the bladder, uterus, fallopian tubes, ovaries, and anterior vaginal wall, yet contiguous extension of urothelial carcinoma to all pelvic organs is rare and routine removal may be unnecessary.
OBJECTIVE.—:
To study pelvic organ involvement in women at radical cystectomy and investigate oncologic outcomes.
DESIGN.—:
Women with bladder cancer who underwent radical cystectomy at the Mayo Clinic and University of Toronto (1980-2018) were evaluated. Cancer-specific survival (CSS) was estimated with the Kaplan-Meier method; comparisons were made with the log-rank test. Associations with CSS were evaluated with Cox proportional hazard modeling.
RESULTS.—:
A total of 70 women with pT4a and 83 with pT3b cancer were studied. Organs involved were vagina (n = 41 of 70; 58.6%), uterus (n = 26 of 54; 48.1%), cervix (n = 15 of 54; 27.8%), fallopian tubes (n = 10 of 58; 17.2%), and ovaries (n = 7 of 58; 12.1%); 22 of 58 patients (37.9%) had >1 organ involved. Of 70 with pT4a cancer, 64 were available for survival analysis by 3 pelvic organ groups: vaginal only, vaginal and/or cervical/uterine, and vaginal and/or cervical/uterine and/or fallopian tubes/ovarian involvement. Three-year CSS for vaginal involvement only was 39%; it was 14% if cervical/uterine involvement, and <1% if fallopian tube/ovarian involvement was included (P = .02). Among 20 women with pT4aN0/Nx and vaginal involvement only, 3-year CSS for vaginal involvement was 50%, whereas among 48 women with pT3bN0/Nx cancer, 3-year CSS was 58%, P = .70.
CONCLUSIONS.—:
Isolated vaginal involvement should be separated from uterine and/or adnexal extension of urothelial carcinoma at pathologic staging. Direct ovarian extension is rare and routine removal may be unnecessary.
AuthorsSvetlana Avulova, Tarik Benidir, John C Cheville, Vignesh T Packiam, Paras Shah, Igor Frank, Matthew K Tollefson, R Houston Thompson, R Jeffrey Karnes, Prabin Thapa, Girish Kulkarni, Stephen A Boorjian
JournalArchives of pathology & laboratory medicine (Arch Pathol Lab Med) Vol. 147 Issue 2 Pg. 202-207 (02 01 2023) ISSN: 1543-2165 [Electronic] United States
PMID35700531 (Publication Type: Journal Article)
Topics
  • Humans
  • Female
  • Urinary Bladder (pathology)
  • Cystectomy (methods)
  • Carcinoma, Transitional Cell (pathology)
  • Urinary Bladder Neoplasms (surgery, pathology)
  • Prevalence
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: